Danaher (DHR) vs Fulgent Genetics (FLGT)
Head-to-head comparison of performance, valuation, growth, profitability and dividends. Prices delayed 15 minutes; data as of Oct 9, 2026.
Summary
Danaher (DHR) has outperformed Fulgent Genetics (FLGT) over the past year, gaining 6.1% versus a loss of 8.8%. Over five years, DHR leads with a -18.6% price change compared with -73.3% for FLGT. Danaher is the larger company by market cap ($152.87 billion vs $572.9 million), about 266.9 times the size.
Danaher pays a dividend yielding 0.66%, while Fulgent Genetics does not currently pay one.
Summary generated from market data by MetaCap's automated system. Methodology
Relative performance
Percent change in share price from the first common trading day shown; excludes dividends.
Head-to-head
| Metric | DHR | FLGT |
|---|---|---|
| Share price | $217.46 | $20.82 |
| Market cap | $152.87B | $572.87M |
| 1-day change | -0.47% | +1.22% |
| YTD return | -5.01% | -20.75% |
| 1-year return | +6.10% | -8.80% |
| 5-year return | -18.61% | -73.31% |
| P/E ratio (TTM) | 38.76 | — |
| Forward P/E | 23.39 | — |
| EPS (TTM) | $5.61 | $-2.82 |
| Dividend yield | 0.66% | 0.00% |
| Annual dividend | $1.44 | $0.00 |
| Revenue (latest FY) | $24.57B | — |
| Revenue growth (YoY) | +2.90% | — |
| Net income (latest FY) | $3.61B | — |
| Gross margin | 59.11% | — |
| Operating margin | 19.09% | — |
| Net margin | 14.71% | — |
| 52-week high | $242.80 | $31.04 |
| 52-week low | $160.93 | $13.46 |
| Distance from 52-week high | -10.44% | -32.93% |
| Analyst consensus | strong_buy | none |
| Avg. price target upside | +9.93% | -8.74% |
| Average volume | 4.74M | 301.04K |
| Shares outstanding | 702.99M | 27.52M |
| Employees | 58,000 | 1,315 |
| Sector | Industrials | Health Care |
| Industry | Industrial Machinery/Components | Medical Specialities |
Highlighted cells mark the higher value for growth, returns, margins and yield, and the lower value for P/E ratios. Highlighting is a mechanical comparison, not a recommendation.
Key differences
- Danaher is about 266.9 times larger than Fulgent Genetics by market value ($152.87B vs $572.87M).
- DHR has outperformed FLGT by 14.9 percentage points over the past year.
- The two companies sit in different sectors: Danaher in Industrials and Fulgent Genetics in Health Care.
About Danaher
DHR stock →Danaher Corporation designs, manufactures, and markets professional, medical, research, and industrial products and services in the United States, China, and internationally. The company operates through Biotechnology, Life Sciences, and Diagnostics segments.
Industrials · Industrial Machinery/Components · 58,000 employees
About Fulgent Genetics
FLGT stock →Fulgent Genetics, Inc. provides clinical diagnostic and therapeutic development solutions to physicians and patients in the United States and internationally.
Health Care · Medical Specialities · 1,315 employees
DHR vs FLGT FAQ
Which is bigger, Danaher or Fulgent Genetics?
Danaher (DHR) is larger, with a market capitalization of $152.87B compared with $572.87M for Fulgent Genetics (FLGT).
Which stock has performed better over the past year, DHR or FLGT?
DHR returned +6.10% over the past 12 months, compared with -8.80% for FLGT (price return, excluding dividends). Past performance does not predict future results.
Which pays a higher dividend, Danaher or Fulgent Genetics?
Danaher pays a dividend yielding 0.66%, while Fulgent Genetics does not currently pay a regular dividend.
Are Danaher and Fulgent Genetics in the same industry?
No. Danaher is in the Industrials sector, while Fulgent Genetics is in Health Care.